Tatva Chintan Pharma Chem Ltd. - TATVA, 543321 corporate action history

Tatva Chintan Pharma Chem Ltd. NSE: TATVA | BSE: 543321

Mid-range Performer

Download real time

939.70 11.65 (1.26%)

51.32% Gain from 52W Low

30,995

NSE+BSE Volume

NSE 16 Jul, 2025 3:28 PM (IST)

Tatva Chintan Pharma Chem Ltd. Bonus history

Tatva Chintan Pharma Chem Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Tatva Chintan Pharma Chem Ltd. Split history

Tatva Chintan Pharma Chem Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. has declared 3 dividends since Sept. 8, 2022.

In the past 12 months, Tatva Chintan Pharma Chem Ltd. has declared an equity dividend amounting to ₹2.00 per share.

At the current share price of ₹939.7000, Tatva Chintan Pharma Chem Ltd.'s dividend yield is 0.21%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
06 Sep 2024	2.00	FINAL	-	Equity Share
08 Sep 2023	2.00	FINAL	-	Equity Share
08 Sep 2022	2.00	FINAL	09 Sep 2022	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Tatva Chintan Pharma Chem Ltd.

The latest board meeting for Tatva Chintan Pharma Chem Ltd. took place on 02 May 2025, for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
02 May 2025	Audited Results & Final Dividend	-
28 Jan 2025	Quarterly Results	-
25 Oct 2024	Quarterly Results	-
24 Jul 2024	Quarterly Results	-
03 May 2024	Audited Results & Final Dividend	-
20 Jan 2024	Quarterly Results	-
02 Nov 2023	Quarterly Results	-
04 Aug 2023	Quarterly Results	-
11 Jul 2023	Preferential issue of shares	-
05 May 2023	Audited Results & Final Dividend	-

See all Board Meetings for Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. Rights history

Tatva Chintan Pharma Chem Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Tatva Chintan Pharma Chem Ltd.